News

Capricor Therapeutics to Highlight Innovations at Investor Events

Capricor Therapeutics to Highlight Innovations at Investor Events

Capricor Therapeutics to Highlight Innovations at Investor Events

Capricor Therapeutics (NASDAQ: CAPR), a leading biotechnology company based in San Diego, is committed to developing transformative cell and exosome-based therapies aimed at addressing rare diseases. Recently, the company announced a series of presentations scheduled at prominent investor conferences, where it will share groundbreaking insights about its research and development progress.

Upcoming Conferences and Presentations

Capricor Therapeutics is slated to participate in exciting investor engagements that promise to highlight the company's innovative approaches to treatment. These presentations will cover its leading product candidate, deramiocel (CAP-1002), and the company's vision for the future of rare disease therapeutics.

Piper Sandler 36th Annual Healthcare Conference

One of the key events is the Piper Sandler 36th Annual Healthcare Conference. This event is a perfect platform for Capricor to engage with investors and industry experts. The fireside chat is scheduled for December 3rd and will run from 11:30 to 11:55 a.m. ET. The presentation will feature discussions around the company's strategic direction and innovative developments in its pipeline.

Oppenheimer Movers in Rare Disease Summit

Following this, Capricor will present at the Oppenheimer Movers in Rare Disease Summit. This session is vital for those interested in the advancements within the field of rare diseases. Capricor’s presentation is set for December 12th from 10:00 to 10:50 a.m. ET, where the focus will be on collaborative approaches and key milestones in product development.

Webcast Access and Further Engagement

For those unable to attend the conferences, the live webcast of the Piper Sandler fireside chat will be available on Capricor's official website under the 'News & Events' section. This not only allows broader access to their insights but also continues to promote transparency and engagement with stakeholders.

Understanding Capricor’s Mission

Capricor Therapeutics is at the forefront of innovation for rare disease treatments. Their lead product, deramiocel (CAP-1002), is a cardiac-derived cell therapy currently progressing through Phase 3 clinical trials for Duchenne muscular dystrophy (DMD). This treatment stands out for its unique immunomodulatory and regenerative capabilities. The ongoing research reaffirms Capricor's dedication to creating impactful solutions for patients facing rare diseases and conditions.

Technological Advancements with Exosome Technology

In addition to deramiocel, Capricor is exploring the potential of exosome technology through their proprietary StealthX™ platform. This platform aims to enable targeted delivery of therapeutics including oligonucleotides and proteins, potentially revolutionizing the approach to diverse diseases. The company’s vision is to broaden the scope of treatment possibilities while addressing significant unmet medical needs.

Looking Ahead

As Capricor prepares to showcase its innovations, the company remains focused on forging partnerships that can enhance its research initiatives and commercial opportunities. This strategic outlook not only supports the development pipeline but also aligns with Capricor’s goal of improving the lives of individuals living with rare diseases.

Frequently Asked Questions

What is the focus of Capricor Therapeutics?

Capricor Therapeutics focuses on developing transformative cell and exosome-based therapeutics for rare diseases, with a strong emphasis on Duchenne muscular dystrophy.

When will Capricor be presenting at investor events?

Capricor is set to present at the Piper Sandler conference on December 3rd and the Oppenheimer Summit on December 12th.

What is deramiocel?

Deramiocel (CAP-1002) is Capricor's leading cardiac-derived cell therapy that is currently undergoing Phase 3 clinical trials for DMD.

How does Capricor utilize exosome technology?

Capricor employs exosome technology through its StealthX™ platform for targeted delivery of therapeutics, aiming to enhance treatment for various diseases.

Where can I access the live webcast of Capricor's presentations?

The live webcast can be accessed on Capricor’s website in the ‘News & Events’ section for those who cannot attend the conferences in person.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 227

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Wulcea Pioneers Safety in Smart Heated Apparel

Updated Category News Views 71

Tech Behind the Warmth and Safety You ever turn on a heated jacket and wonder if it'll keep you safe as much as warm? That's the scene with Wulcea, a brand diving headfirst into the smart heated clothing market. People are waking up to what’s inside these technological coats, not just how they feel on a frosty walk. It’s the kind of scenario where safety meets...

Continue Reading
UBCF & GGP Join Forces for Nationwide Pink Bag Drive

Updated Category News Views 185

Caring Through Community: Pink Bag Events Unroll What do you get when compassion meets action? That's the story with the United Breast Cancer Foundation (UBCF) and GGP's Pink Bag Event. Here in 2026, these folks are doing something so damn important, you'd wonder why more don’t follow suit. For the fifth straight year, they're rolling out a campaign that bridges the gap...

Continue Reading
Rural AI Skills Gap Uncovered: Challenges and Solutions

Updated Category News Views 94

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 213

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 132

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
Fashion and Philanthropy Unite at UBCF Kick-off Party

Updated Category News Views 166

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 162

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Updated Category News Views 75

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Continue Reading
Yangtze River Culture Festival Spotlights Integration, Tradition

Updated Category News Views 0

A Celebration of Culture and Integration Here's an event that flips the script on the typical festival circuit: the 2026 Yangtze River Culture Festival. It's as much about heritage as it is about economics, dovetailing culture with tourism in a way that makes wallets a little fatter and souls a little richer. Kicking off in Yonglian Village, Zhangjiagang, this festival...

Continue Reading

Top 5 Most Recently Viewed Articles

Digi Power X Launches $100 Million Fund to Drive Expansion

Updated Category News Views 356

Digi Power X Announces $100 Million Equity Program MIAMI – Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), a key player in the development of innovative energy infrastructure and data centers for high-performance computing, is thrilled to share the initiation of its at-the-market equity program. This announcement comes as part of...

Continue Reading
SAP's Earnings Report: Key Insights and Market Reactions

Updated Category News Views 175

Understanding SAP's Impact on the Market As one of Europe's largest software firms, SAP plays a critical role in shaping market sentiments. The company is set to announce its third-quarter earnings, which many analysts believe will significantly influence the trajectory of both the German and broader European markets. Current Market Context The context surrounding SAP's...

Continue Reading
Wispr Flow Joins AWS Generative AI Accelerator for Innovation

Updated Category News Views 190

Wispr Flow Joins AWS Generative AI Accelerator for Innovation Wispr Flow, an innovative voice dictation platform, is excited to announce its selection for the second cohort of the AWS Generative AI Accelerator. This remarkable opportunity is set to significantly enhance its mission of improving communication technology. Through this program, startups receive AWS credits,...

Continue Reading
European Commission Approves Biocon Biologics' New Biosimilars

Updated Category News Views 300

European Commission Grants Marketing Authorization Biocon Biologics Ltd, a leading global biosimilars company, has achieved a significant milestone with the approval from the European Commission (EC) for its Denosumab biosimilars, Vevzuo® and Evfraxy®. This marks a pivotal advancement in the treatment of various bone health conditions across the European Union (EU)....

Continue Reading
Fermi America Secures Major Acquisition in Clean Energy Sector

Updated Category News Views 475

Fermi America's Strategic Acquisition of Clean Energy Generation - The Only Company that Can Deliver One GW of AI Power in 2026 Fermi America has made a significant move to secure over 600 megawatts of clean gas generation, aiming to deliver one gigawatt of online power by the end of 2026. The organization is on a mission to become a dominant player in both the energy and...

Continue Reading